November 24, 2014

Omnicare and McKesson on Monday announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. 

November 24, 2014

Perrigo on Monday announced that it has agreed to market the authorized generic version of Astellas U.S.' Protopic ointment 0.1% and 0.03%. 

November 24, 2014

VOA Associates on Monday announced the opening of a new Walgreens Health System Pharmacy at Northwestern Memorial Hospital’s Galter Pavilion.

November 21, 2014

The membership of the Pharmacy Quality Alliance has endorsed a new performance measure, Statin Use in Persons with Diabetes, the group announced Friday. 

November 21, 2014

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

November 20, 2014

Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.

 

November 20, 2014

Walgreens may be in a year of transition through 2015.

 

November 20, 2014

Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023. 

November 20, 2014

The Generic Pharmaceutical Association on Thursday emphasized the savings generic medicines bring to the table in light of rising brand prices. 

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 20, 2014

Moberg Pharma AB on Thursday announced that Jeff Vernimb has been named general manager for its U.S. operations and a member of Moberg's management team, effective Dec. 15.

 

November 20, 2014

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

November 20, 2014

Rite Aid on Thursday announced Quality Independent Physicians, based in Louisville, Ky., as the latest healthcare provider to join its Rite Aid Health Alliance initiative. 

 

November 19, 2014

Nearly eight in 10 Americans (78%) would consider seeing a healthcare professional virtually for at least one healthcare need, according to a new Harris Poll.

November 19, 2014

Emdeon announced it has entered into a definitive agreement to acquire Change Healthcare.

November 19, 2014

The Food and Drug Administration opened a public docket and requested comments on proposed criteria for “first generic” abbreviated new drug application submissions.

 

November 19, 2014

MinuteClinic has opened New Mexico's first retail medical clinics inside three CVS/pharmacy stores in Albuquerque and one in Rio Rancho.

November 18, 2014

Camber Pharmaceuticals on Monday announced their selection as a 2014 “Supplier of the Year” at Anda’s annual Supplier Strategy Meeting in Doral, Fla.

November 18, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at the impact of the Hatch-Waxman act and Q&A's with industry leaders, in this multi-page report.

November 18, 2014

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.

November 17, 2014

Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock, the company announced Monday.

November 17, 2014

A recent study by Field Agent examined what consumers are planning to do to keep themselves and their families healthy this fall.

November 17, 2014

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

November 17, 2014

DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act.